Ideas to Action:

Independent research for global prosperity

Views from the Center

CGD experts offer ideas and analysis to improve international development policy. Also check out our Global Health blog and US Development Policy blog.

 

A Reason for Happier Meals at McDonald's: Fewer Antibiotics in Your Chicken

McDonald's has just gone global with its commitment to serve chicken free from antibiotics that are critically important to human health. Building on a similar phase-out in its US chicken supply in 2016, the company will ban critical antibiotic use from sourced chicken in a handful of high-income countries and Brazil in 2018, expanding to a longer list of “designated markets” by 2027. That's evidence of both the potential to reduce global antibiotic use in livestock and the vital role consumers can play in speeding progress.

Young Professionals and the Future of Global Development

Our concluding message to young professionals and young people in general is this: engage with us. Tell us what you think is working in development, what isn’t, and why. You will help advance CGD’s mission to fight poverty through innovative, evidence-based policies by keeping the dialogues we foster energetic, fresh, and as inclusive as possible.

Bridging the Humanitarian-Development Divide: Three Priorities from Three Global Leaders

How can the world find realistic, workable solutions to bridge the divide between humanitarian response and development assistance? This question was front and center at a high-level discussion, co-hosted by CGD and the International Rescue Committee (IRC), in the run up to last week’s Spring Meetings. The event marked the launch of a new CGD-IRC report, which puts forth one emerging solution to the refugee crisis—compact agreements between host governments and development and humanitarian actors. The discussion featured three global leaders on the frontline of today’s displacement challenge: Jordan’s Minister of Planning and International Cooperation Imad Fakhoury, World Bank CEO Kristalina Georgieva, and IRC President and CEO David Miliband. Here are three takeaways.

An Ambitious Goal for International Cooperation in 2017: A Global Treaty to Tackle Antimicrobial Resistance

Earlier this month, evidence emerged that a Nevada woman who died last September had contracted a superbug resistant to all 26 available antibiotics, including colistin, the drug of last resort. If left unchecked, antimicrobial resistance (AMR) could cause up to 10 million deaths a year by 2050 with a cumulative loss of $100 trillion to the global economy. The misuse of antibiotics in human medicine allows bacteria to evolve resistance to many life-saving drugs. But their excessive and inappropriate use in farm animals—which consume 70-80 percent of antibiotics sold in the United States—is another key factor accelerating drug resistance globally.